ECM Weekly (14th Oct 2024) - Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
467 Views
China Healthcare Weekly (Oct.13)-Genor to Acquire Edding, RemeGen's Bleak Outlook, Zai Lab's Trouble
Genor/Edding are merging through a reverse takeover, but valuation is unsatisfactory. Remegen is negative example among China Biotech.Weak...
547 Views
HK Short Interest Weekly: Ping An, Baba, Jd, CCB, CNOOC, China Mobile, Akeso, Zhaojin Mining
We analyzed the latest HK SFC report for aggregate short position as of Sep 27th and highlight short interest changes in Ping An, Baba, Jd, CCB,...
288 Views
Pre-IPO Sichuan Biokin Pharmaceutical - Would Investors Be Willing to Take a Gamble?
Biokin's future hinges on collaboration with BMS for BL-B01D1, as traditional business shrink due to VBP/fierce competition.Overvaluation poses...
625 Views
Hong Kong Connect Flows (Sep): Weak Inflows Ex-Alibaba
We noted 12 months of inflows for Southbound connect stocks and highlighted inflows into Alibaba, Kuaishou, Anta, HKEx, China Resource Land, China...
258 Views